新政出台为化妆品产业持续健康发展注入强劲动力

Core Viewpoint - The new regulatory reforms introduced by the National Medical Products Administration aim to enhance the quality and competitiveness of the cosmetics industry in China, with a vision for modernization and international alignment by 2035 [2][7]. Group 1: Regulatory Reforms - The "Opinions" document outlines 24 reform proposals and 48 specific measures to improve the cosmetics industry [3]. - Key measures include the establishment of a fast-track approval process for new efficacy cosmetics, allowing international new products to enter the market without prior sales proof, and fostering the silver economy by addressing the needs of the elderly [4][5]. Group 2: Innovation and Market Dynamics - The reforms focus on the front end of the industry value chain, emphasizing innovation, product entry, and market introduction [4]. - The introduction of a dedicated review channel for new efficacy cosmetics is expected to lower R&D costs and provide clear policy guidance for companies [4]. Group 3: Digitalization and Efficiency - New electronic labeling initiatives are set to enhance regulatory digitalization, allowing consumers to access comprehensive product information via QR codes [6]. - Measures to streamline the review process include reducing the review time for high-risk changes from 90 to 60 days and for low-risk changes to 45 days, significantly improving efficiency [6]. Group 4: Quality Management and Market Growth - A three-year action plan will be implemented to enhance the quality management systems of cosmetics companies, particularly benefiting small and medium-sized enterprises [7]. - The Chinese cosmetics market is projected to exceed 1 trillion yuan in transaction value by 2024, with domestic products accounting for over 55.2% of sales [7].